These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24857619)

  • 1. Interferon-beta plus ribavirin therapy can be safely and effectively administered to elderly patients with chronic hepatitis C.
    Nomura H; Miyagi Y; Tanimoto H; Yamashita N
    J Infect Chemother; 2014 Aug; 20(8):489-92. PubMed ID: 24857619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of interferon beta-1a with or without ribavirin in Asian patients with chronic hepatitis C.
    Chan HL; Ren H; Chow WC; Wee T;
    Hepatology; 2007 Aug; 46(2):315-23. PubMed ID: 17654600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model incorporating the ITPA genotype identifies patients at high risk of anemia and treatment failure with pegylated-interferon plus ribavirin therapy for chronic hepatitis C.
    Kurosaki M; Tanaka Y; Nishida N; Sakamoto N; Enomoto N; Matsuura K; Asahina Y; Nakagawa M; Watanabe M; Sakamoto M; Maekawa S; Tokunaga K; Mizokami M; Izumi N
    J Med Virol; 2013 Mar; 85(3):449-58. PubMed ID: 23297176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Protease Inhibitor with Induction Therapy with Natural Interferon-β in Patients with HCV Genotype 1b Infection.
    Kishida Y; Imaizumi N; Tanimura H; Kashiwamura S; Kashiwagi T
    Int J Mol Sci; 2016 Mar; 17(3):350. PubMed ID: 27005617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C.
    Pellicano R; Craxi A; Almasio PL; Valenza M; Venezia G; Alberti A; Boccato S; Demelia L; Sorbello O; Picciotto A; Torre F; Ideo G; Cattaneo C; Berrutti M; Rizzetto M
    World J Gastroenterol; 2005 Aug; 11(29):4484-9. PubMed ID: 16052676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.
    Sato A; Yamauchi M; Yamada T; Kumano R; Adachi K; Ishii T; Hayashi M; Kumon D
    Clin J Gastroenterol; 2014 Aug; 7(4):355-60. PubMed ID: 25132867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta plus ribavirin for patients with hepatitis C virus genotype 1: a randomised pilot trial.
    Enomoto M; Tamori A; Kawada N; Jomura H; Nishiguchi S; Saibara T; Onishi S; Mochida S; Fujiwara K
    Gut; 2006 Jan; 55(1):139-40. PubMed ID: 16344588
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of ITPA gene variation and serum ribavirin concentration with a decline in blood cell concentrations during pegylated interferon-alpha plus ribavirin therapy for chronic hepatitis C.
    Nakagawa M; Sakamoto N; Watanabe T; Nishimura-Sakurai Y; Onozuka I; Azuma S; Kakinuma S; Nitta S; Kiyohashi K; Kusano-Kitazume A; Murakawa M; Yoshino K; Itsui Y; Tanaka Y; Mizokami M; Watanabe M;
    Hepatol Int; 2013 Mar; 7(1):153-61. PubMed ID: 26201629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of interferon beta treatment for chronic HCV hepatitis.
    Festi D; Sandri L; Mazzella G; Roda E; Sacco T; Staniscia T; Capodicasa S; Vestito A; Colecchia A
    World J Gastroenterol; 2004 Jan; 10(1):12-6. PubMed ID: 14695760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is interferon-beta an alternative treatment for chronic hepatitis C?
    Moreno-Otero R; Trapero-Marugán M; Gómez-Domínguez E; García-Buey L; Moreno-Monteagudo JA
    World J Gastroenterol; 2006 May; 12(17):2730-6. PubMed ID: 16718760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis for ribavirin-related anemia using eicosapentaenoic acid in chronic hepatitis C patients.
    Suzuki M; Inage E; Minowa K; Saito N; Naritaka N; Tsubahara M; Ohtsuka Y; Tokita A; Shimizu T
    Pediatr Int; 2012 Aug; 54(4):528-31. PubMed ID: 22375604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to improve virological sustained response rate by interferon therapy for patients with chronic hepatitis C.
    Izumi N
    J Gastroenterol; 2001 Apr; 36(4):281-3. PubMed ID: 11324734
    [No Abstract]   [Full Text] [Related]  

  • 14. Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients.
    Fabrizi F; Lunghi G; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Nov; 24(10):1413-22. PubMed ID: 17081162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New-onset type 1 diabetes mellitus and anti-aquaporin-4 antibody positive optic neuritis associated with type 1 interferon therapy for chronic hepatitis C.
    Kawazoe T; Araki M; Lin Y; Ogawa M; Okamoto T; Yamamura T; Wakakura M; Murata M
    Intern Med; 2012; 51(18):2625-9. PubMed ID: 22989839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurosarcoidosis associated with interferon therapy.
    Miwa H; Furuya T; Tanaka S; Mizuno Y
    Eur Neurol; 2001; 45(4):288-9. PubMed ID: 11385273
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients.
    Sezaki H; Suzuki F; Hosaka T; Akuta N; Fukushima T; Hara T; Kawamura Y; Kobayashi M; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
    Hepatol Res; 2014 Oct; 44(10):E163-71. PubMed ID: 24397402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ITPA gene variant protects against anemia induced by pegylated interferon-α and ribavirin therapy for Japanese patients with chronic hepatitis C.
    Sakamoto N; Tanaka Y; Nakagawa M; Yatsuhashi H; Nishiguchi S; Enomoto N; Azuma S; Nishimura-Sakurai Y; Kakinuma S; Nishida N; Tokunaga K; Honda M; Ito K; Mizokami M; Watanabe M
    Hepatol Res; 2010 Nov; 40(11):1063-71. PubMed ID: 20977565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic thrombocytopenic purpura during treatment with interpheron].
    Serrano A; Xicoy B; Grifols JR; Ribera JM
    Med Clin (Barc); 2007 Feb; 128(7):276-7. PubMed ID: 17335744
    [No Abstract]   [Full Text] [Related]  

  • 20. Occurrence of clinical depression during combination therapy with pegylated interferon alpha or natural human interferon beta plus ribavirin.
    Nomura H; Miyagi Y; Tanimoto H; Yamashita N; Oohashi S; Nishiura S
    Hepatol Res; 2012 Mar; 42(3):241-7. PubMed ID: 22176275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.